Carmen Vigo‐Pelfrey
Carmen Vigo‐Pelfrey publishes mostly in Physiology, Molecular Biology and Psychiatry and Mental health, on topics such as Alzheimer's disease research and treatments, Amyloidosis: Diagnosis, Treatment, Outcomes and Dementia and Cognitive Impairment Research.
- World rank
- #699,026 of 7,710,434 ranked researchers
- Rank in United States
- #236,343 of 1,627,098
- Works
- 21
- Citations
- 8.8k
- Citations per work
- 419.9
What does Carmen Vigo‐Pelfrey research?
Carmen Vigo‐Pelfrey's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (29%), Agricultural and Biological Sciences (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences941.3%
- Medicine941.3%
- Life Sciences732.7%
- Everything else526.0%
- 1Physiology29% of their works
- 2Molecular Biology24% of their works
- 3Psychiatry and Mental health9% of their works
- 4Biochemistry5% of their works
- 5Infectious Diseases3% of their works
- 6Food Science3% of their works
Research topics
- Alzheimer's disease research and treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Dementia and Cognitive Impairment Research
- Prion Diseases and Protein Misfolding
- Amino Acid Enzymes and Metabolism
- Lipid Membrane Structure and Behavior
- Computational Drug Discovery Methods
- Supramolecular Self-Assembly in Materials
Which keywords describe Carmen Vigo‐Pelfrey's research?
The keywords of their largest research topics: Amyloid Hypothesis, Tau Pathology, Cardiac Amyloidosis, Transthyretin, Alzheimer's Disease, Mild Cognitive Impairment, Molecular Basis and Prion Diseases.
- Virtual Screening
- Self-Assembly
- Membrane Lipids
- D-Serine
- Prion Diseases
- Mild Cognitive Impairment
- Transthyretin
- Tau Pathology
- Amyloid Hypothesis
- Cardiac Amyloidosis
- Alzheimer's Disease
- Molecular Basis
- Amino Acid Transporters
- Lipid Rafts
- Molecular Docking
- Supramolecular
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Amyloid Hypothesis161 topic
- Tau Pathology161 topic
- Cardiac Amyloidosis71 topic
- Transthyretin71 topic
- Alzheimer's Disease51 topic
- Mild Cognitive Impairment51 topic
- Molecular Basis41 topic
- Prion Diseases41 topic
- Amino Acid Transporters31 topic
- D-Serine31 topic
- Lipid Rafts21 topic
- Membrane Lipids21 topic
- Molecular Docking21 topic
- Self-Assembly21 topic
- Supramolecular21 topic
- Virtual Screening21 topic
Where does Carmen Vigo‐Pelfrey work?
Carmen Vigo‐Pelfrey's main affiliation in the publication record is Athena Group (United States), United States.
How many publications and citations does Carmen Vigo‐Pelfrey have?
OpenAlex counts 21 works and 8,817 citations for Carmen Vigo‐Pelfrey, an h-index of 18, ranking #699,026 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carmen Vigo‐Pelfrey. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.